Categories U.S. Markets News

Does McDonald’s French fries cure baldness? Here’s the truth

McDonald’s recently had its famous French fries in news for the weirdest of reasons. A study by Biomaterials noted that a chemical found in the fries was used by researchers at a Japanese University to grow hair on mice.

Thanks to some news articles, the report soon created rumors that the fries would cure baldness in human beings. Before you ditch your hair cream for junk food, let’s find out the truth.

As per the McD site, their French fries contain the following ingredients: potatoes, vegetable oil, natural beef flavor, dextrose, sodium acid pyrophosphate and salt. Apart from these, in small font at the end of the page, the company says that it uses “vegetable oil blend with citric acid added as a processing aid and dimethylpolysiloxane to reduce oil splatter when cooking.”

Drugs.com states that this chemical is otherwise used in cosmetic and hygiene products such as make-up, sunscreen and deodorants as a conditioning agent. Though the chemical is believed to be carcinogenic under high temperature or excess intake, FDA has not yet declared it as dangerous.

Coming back to hair growth, dimethylpolysiloxane is the same chemical that was used by the Japanese researchers to experiment on mice. The face of the matter is that even the researchers have so far not been able to infer that the chemical spurs hair growth. They have stated that more studies are required for conclusive results.     

So before you recommend French fries to your bald friend next time, remember this article. I’m lovin’ it anyways, even without any cure!

Most Popular

QCOM Earnings: Qualcomm Q2 2024 revenue and profit beat Street view

Semiconductor company Qualcomm, Inc. (NASDAQ: QCOM) reported an increase in earnings and revenues for the second quarter of 2024. The numbers came in above analysts' estimates. At $9.39 billion, March-quarter

Key takeaways from Amazon’s Q1 2024 earnings report

Amazon.com Inc. (NASDAQ: AMZN) had an upbeat start to fiscal 2024, delivering strong growth across the business in the first three months of the year. While the cloud segment continues

Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report

Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results. Although the top and bottom line numbers decreased

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top